問卷

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol Number2-001

2008-09-01 - 2009-09-30

Phase II

Terminated5

ICD-10A41.89

Other specified sepsis

ICD-10R65.10

Systemic inflammatory response syndrome (SIRS) of non-infectious origin without acute organ dysfunction

ICD-10R65.11

Systemic inflammatory response syndrome (SIRS) of non-infectious origin with acute organ dysfunction

ICD-10R65.20

Severe sepsis without septic shock

ICD-9038.8

Other specified septicemias

  • Trial Applicant

    IQVIA RDS Taiwan Ltd.

  • Sponsor

  • Trial scale

    Multi-Regional Multi-Center

  • Update

    2025/08/20

Investigators and Locations

Principal Investigator 柯文哲 Division of General Surgery

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator TsanLung Hwang Division of General Surgery

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator Yin-Ching Chuang Division of Infectious Disease

Co-Principal Investigator

  • 鄭高珍 Division of General Internal Medicine
  • 陳欽明 Division of General Internal Medicine
  • 沈修年 Division of General Internal Medicine
  • Wei-Ting Chang Division of Infectious Disease
  • 余文良 Division of General Internal Medicine
  • 楊煦星 Division of General Internal Medicine
  • 楊俊杰 Division of General Internal Medicine
  • 蔡季倫 Division of General Internal Medicine
  • 陳奇祥 Division of General Internal Medicine
  • 陳志金 Division of General Internal Medicine

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator 廖文進 Division of General Surgery

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator 林楷煌 Division of General Internal Medicine

Co-Principal Investigator

  • 王竹賢 Division of General Internal Medicine
  • 吳育政 Division of General Internal Medicine
  • 邱駿清 Division of General Internal Medicine
  • 洪明煌 Division of General Internal Medicine
  • 吳莘華 Division of General Internal Medicine

The Actual Total Number of Participants Enrolled

0 Terminated

Condition/Disease

Objectives

Test Drug

Active Ingredient

Dosage Form

Dosage

Endpoints

Inclution Criteria

The Estimated Number of Participants

  • Taiwan

    12 participants

  • Global

    750 participants